AB928, a dual antagonist of the A(2a)R and A(2b)R adenosine receptors for the treatment of cancer
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2017)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined